Daily News Podcast

Polysomnography beats Fitbit


 

Fitbit and sleep applications for smartphones should not be recommended as screening tools for obstructive sleep apnea. Also today, there is no evidence for the disease-modifying effect of levodopa in Parkinson’s Disease, and ablation surpassed drugs for raising quality of life for atrial fibrillation.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Prescribed opioids and pneumonia risk
MDedge Endocrinology
Subclinical hypothyroidism boosts immediate risk of heart failure
MDedge Endocrinology
Oral GLP-1 receptor agonist pioneered in T2DM trial
MDedge Endocrinology
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
MDedge Endocrinology
Survey: Americans support Medicare for all
MDedge Endocrinology
Useful financial and efficiency advice to practices is hard to come by
MDedge Endocrinology
Drug-pricing policies find new momentum as ‘a 2020 thing’
MDedge Endocrinology
Lessons learned from the PCSK9 inhibitor trials
MDedge Endocrinology
SGLT inhibitor still possible for T1DM, despite FDA committee vote
MDedge Endocrinology
PCSK9 inhibition isn’t the answer for high Lp(a)
MDedge Endocrinology